Present and Future of Allogeneic Natural Killer Cell Therapy
about
NK Cells in HIV DiseaseNatural Killer Cell Recognition of Melanoma: New Clues for a More Effective ImmunotherapyManufacturing Natural Killer Cells as Medicinal ProductsAntitumor effect of a polysaccharide isolated from Phellinus pullus as an immunostimulant.Epigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid.Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies.PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells.Old game, new players: Linking classical theories to new trends in transplant immunology.Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.Generation of "Off-the-Shelf" Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells.Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.MRI-guided interventional natural killer cell delivery for liver tumor treatment.Real-Time Tracking of Ex Vivo-Expanded Natural Killer Cells Toward Human Triple-Negative Breast Cancers.Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor TherapyNatural Killer Cells: Development, Maturation, and Clinical Utilization
P2860
Q26752833-9FAB7598-CE54-43A0-839E-4EB82CE6DF32Q26771449-FA58C6F3-6D7E-4FF9-967B-E3690EC2B9CFQ28069992-FB608313-F6CA-47E3-B7C5-C7114612CA6EQ36639829-3683AB6E-032C-4CC7-BAC7-A2EC5B50452BQ36853857-33091EB9-C58D-4D5D-9E50-D0BA06CEA823Q37224604-016D4E67-6222-4155-9921-64B8AB8FA8E9Q37565475-3AFB892D-D62F-4670-A660-1B70FABEB32DQ37662989-9F03961E-5762-483C-824A-23166ABC79BCQ38670280-049DED83-2EE3-4776-843B-0C5BA76B0F36Q38739764-4DF5941D-E732-402A-A91E-00EBBD01D4A8Q45872592-947F08D6-31FB-4548-B6AA-A159BFEE4307Q46350666-A906C5DF-A260-449D-9240-DA9A83607EEDQ48590636-16304E18-34DB-4489-908E-5A9AFDAE2E66Q52779233-A755E64F-3338-4C86-B144-8A1F577EA541Q54987276-6B8DE809-6898-4161-A1F5-BF19CB97CC16Q55088034-D503FAEB-58BD-44CA-B698-042804AB99EAQ58727819-09781177-C384-4F90-B83C-08A02BD2537BQ58785734-59E4332E-6D77-4A92-90CE-8C32BA8579D5
P2860
Present and Future of Allogeneic Natural Killer Cell Therapy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Present and Future of Allogeneic Natural Killer Cell Therapy
@ast
Present and Future of Allogeneic Natural Killer Cell Therapy
@en
type
label
Present and Future of Allogeneic Natural Killer Cell Therapy
@ast
Present and Future of Allogeneic Natural Killer Cell Therapy
@en
prefLabel
Present and Future of Allogeneic Natural Killer Cell Therapy
@ast
Present and Future of Allogeneic Natural Killer Cell Therapy
@en
P2093
P2860
P356
P1476
Present and Future of Allogeneic Natural Killer Cell Therapy
@en
P2093
Mi Young Jung
Yu Kyeong Hwang
P2860
P356
10.3389/FIMMU.2015.00286
P577
2015-06-03T00:00:00Z